Visalytics
Visalytics
approved EB-2 (NIW)

Associate Researcher

Biochemistry · Nepal · 2022-03-24

Processing Time
372 days
Decision Date
2022-03-24
Location
Kansas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue investigating the mechanisms of proteins and enzymes to aid in the understanding and treatment of cancer, Alzheimer’s disease, and other human diseases. His work specifically focuses on the mechanism of y-secretase activation and the effects of Alzheimer-causing mutations to develop novel drug therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses urgent public health concerns including Alzheimer's disease and cancer, which are of clear national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 5 years of direct research experience, a record of published work, and has secured funding from the NIH.

3 Waiver of Job Offer and Labor Certification Met

The urgent national need for Alzheimer's research and the petitioner's unique contributions make a waiver beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on 6 peer-reviewed journal articles (4 first-authored) with 34 citations, 5 years of research experience, and funding from the National Institutes of Health. The case was supported by 4 expert recommendation letters and demonstrated significant impact on the treatment of Alzheimer's disease, satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · Albania

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-10
The petitioner proposes to continue her research in molecular biology, specifically focusing on identifying drug targets and their mechanisms of action in complex biological samples. Her work utilizes proteogenomic approaches to elucidate the relationship between genetic mutations and protein functions in breast cancer. This research is intended to enhance the understanding of disease mechanisms and inform the development of targeted therapies for cancer, metabolic disorders, and neurodegenerative conditions.
View Case

Scientist

Research and Development · India

WeGreened EB-2 (NIW) approved
Alabama 6 days 2024-03-07
The petitioner proposes to continue research using mouse model systems, high-resolution imaging, and molecular biology techniques to discover the mechanisms and molecular pathology of Parkinson’s disease. The work focuses on identifying effective therapeutic targets to improve patient quality of life and alleviate the economic burden associated with the condition.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 95 days 2022-04-11
The petitioner proposes to continue research evaluating how changes in RNA impact protein synthesis and influence the progression of health burdens including cancer, aging, and infectious diseases. He utilizes expertise in RNA folding, ribosome assembly, and protein synthesis mechanisms to identify novel therapeutic targets for these disorders.
View Case

Scientist

Biotechnology · Zimbabwe

WeGreened EB-2 (NIW) approved
Massachusetts 297 days 2025-03-06
The petitioner proposes to develop safe and effective gene therapies and delivery systems to improve treatment options for rare and complex disorders. Her work specifically focuses on uncovering how protofibrils contribute to neuronal damage in Alzheimer’s disease to support the development of targeted drug therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Nepal

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-03-24.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 372 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nepal All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist